Skip to main content
Mirla Avila, MD, Neurology, Lubbock, TX, University Medical Center

MirlaLAvilaMDMD(She/Her)

[Pronunciation: she]

Neurology Lubbock, TX

Neuroimmunology/Multiple Sclerosis

Interim Chair, Program Director and Associate Professor of Neurology TTUHSC Director of the TT Comprehensive Care Multiple Sclerosis Clinic

Dr. Avila is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Avila's full profile

Already have an account?

Summary

  • Board certified Neurologist with subspecialty on Multiple Sclerosis and Neuroimmunology. Active in research and education.
    Associate Professor of Neurology and Associate Program Director of Neurology TTUHSC.

Education & Training

  • Cornell University
    Cornell University Medical nutrition and Healthy living, e-Cornell , 2021 - 2022
  • Texas Tech University Health Sciences Center at Lubbock
    Texas Tech University Health Sciences Center at LubbockResidency, Neurology, 2013 - 2016
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Neuroimmunology & Multiple Sclerosis, 2007 - 2011
  • Universidad de Monterrey
    Universidad de MonterreyClass of 1999

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2016 - 2024
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Texas Tech University Health Sciences Center 99 percentile 2019 TTUHSC, 2019
  • Unsung Hero Award TTUHSC, 2018
  • Award for excellence in teaching at integrated neuroscience TTUHSC, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • 1. Multiple Sclerosis and Schizophrenia, is Epstein Barr virus a possible immune trigger for these chronic conditions  
    . Mirla Avila MD, Mirla Nicole Martinez, International Journal of MS Care, 5/2023
  • Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 infection, a Case Series  
    Mirla Avila, Yuanyuan Tan, Roberto Hernandez, Hafsa Zuberi, Neurology and Therapy, 11/18/2022
  • Aquaporin-4 Protein Antibody Seropositivity after Acute SARS-CoV-2 Infection  
    Tan Y, Zuberi HZ, Hernandez RM, Avila M, J Neurol Psychol, 9/2022
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Efficacy of Rituximab in Adult and Pediatric Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: A Systematic Review and Meta-analysis.
    S.Thakolwiboon, J. Pan, A. Karukote, H Zhao-Fleming, M. Avila, ECTRIMS 2020
  • Neuroprotective effect of AZ257, a novel urea-based dopamine transporter inhibitor, in the experimental autoimmune encephalitis (EAE) mouse model,
    Mirla Avila MD, Md Ashraf-Uz-Zaman, Guangchen Ji, Smathorn Thakolwiboon MD, Jie Pan MD, Sadisna Shahi, Md Sanaullah Sajib, Paul C. Trippier, Constantinos M. Mikelis, ..., American Academy of Neurology, Seattle WA, 2022
  • Vaginal estriol as a potential adjunctive therapy for MS remyelination
    Mirla L. Avila, J. Pan, R Hernandez, D Chi, S. Thalkolwiboon, A. Peiris, K.Freedman, C. Thompson, J. Garza, American Academy of Neurology, Seattle WA, 2022
  • Join now to see all

Lectures

  • The evolving role of vaginal estriol in the treatment of MS 
    Texas Neurology Society, San Antonio TX - 7/2022
  • Differential diagnosis of MS new entities 
    LACTRIMS - Paraguay - 11/2018

Press Mentions

  • This MS Neurologist Is No Longer a ‘Secret’ Singer-Songwriter
    This MS Neurologist Is No Longer a ‘Secret’ Singer-SongwriterMarch 27th, 2024
  • Pharmacy Researchers Receive Patent for Chemical Probe
    Pharmacy Researchers Receive Patent for Chemical ProbeMarch 31st, 2022

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations